Search research articles
Contact Us
Filters
Showing results (31-40 of 492) with videos related to
Page
of 50
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 20, 2016
Targeted α-Based Treatment of Metastatic Castration-Resistant Prostate Cancer: Revolutionizing Systemic Radiotherapy?
Wim J G Oyen, Johann S de Bono
European Urology
|
February 20, 2025
Mind the Gap: The Disconnect Between Clinical Trials and Real-World Oncology Patients
Tarek Taha, Emma Hall, Johann S de Bono
Current Opinion in Oncology
|
March 27, 2015
What have we learned from exceptional tumour responses?: Review and perspectives
Niven Mehra, David Lorente, Johann S de Bono
Seminars in Oncology
|
October 2, 2023
PARP inhibitors for prostate cancer
Ossian Longoria, Nick Beije, Johann S de Bono
Molecular Cancer Therapeutics
|
September 3, 2010
Targeting insulin-like growth factor signaling: rational combination strategies
David Olmos, Bristi Basu, Johann S de Bono
The Journal of Steroid Biochemistry and Molecular Biology
|
September 25, 2014
Targeting extra-gonadal androgens in castration-resistant prostate cancer
Emily Grist, Johann S de Bono, Gerhardt Attard
European Urology Focus
|
January 26, 2021
Prostate-specific Membrane Antigen Theranostics for Prostate Cancer Care: A Need to Prove Clinical Utility
Alec Paschalis, Bertrand Tombal, Johann S de Bono
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2017
Acquiring evidence for precision prostate cancer care
J Mateo, S Carreira, J S de Bono
JAMA Oncology
|
July 17, 2015
Cabozantinib-Getting Under the Skin of Cutaneous Toxicity
Anuradha Jayaram, Zafeiris Zafeiriou, Johann S de Bono
Clinical Chemistry
|
December 4, 2012
Novel strategies to test biological hypotheses in early drug development for advanced prostate cancer
Roberta Ferraldeschi, Gerhardt Attard, Johann S de Bono
Page
of 50
Search research articles
Search
Showing results (31-40 of 492) with videos related to
Sort By:
Page
of 50
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 20, 2016
Targeted α-Based Treatment of Metastatic Castration-Resistant Prostate Cancer: Revolutionizing Systemic Radiotherapy?
Wim J G Oyen, Johann S de Bono
European Urology
|
February 20, 2025
Mind the Gap: The Disconnect Between Clinical Trials and Real-World Oncology Patients
Tarek Taha, Emma Hall, Johann S de Bono
Current Opinion in Oncology
|
March 27, 2015
What have we learned from exceptional tumour responses?: Review and perspectives
Niven Mehra, David Lorente, Johann S de Bono
Seminars in Oncology
|
October 2, 2023
PARP inhibitors for prostate cancer
Ossian Longoria, Nick Beije, Johann S de Bono
Molecular Cancer Therapeutics
|
September 3, 2010
Targeting insulin-like growth factor signaling: rational combination strategies
David Olmos, Bristi Basu, Johann S de Bono
The Journal of Steroid Biochemistry and Molecular Biology
|
September 25, 2014
Targeting extra-gonadal androgens in castration-resistant prostate cancer
Emily Grist, Johann S de Bono, Gerhardt Attard
European Urology Focus
|
January 26, 2021
Prostate-specific Membrane Antigen Theranostics for Prostate Cancer Care: A Need to Prove Clinical Utility
Alec Paschalis, Bertrand Tombal, Johann S de Bono
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2017
Acquiring evidence for precision prostate cancer care
J Mateo, S Carreira, J S de Bono
JAMA Oncology
|
July 17, 2015
Cabozantinib-Getting Under the Skin of Cutaneous Toxicity
Anuradha Jayaram, Zafeiris Zafeiriou, Johann S de Bono
Clinical Chemistry
|
December 4, 2012
Novel strategies to test biological hypotheses in early drug development for advanced prostate cancer
Roberta Ferraldeschi, Gerhardt Attard, Johann S de Bono
Page
of 50